|
New for Florida Hospital!
ZevalinTM for Recurrent/Refractory Non-Hogkin's Lymphoma
GliasiteTM Brain Tumor Brachytherapy System
Breast Care Program
We at Florida Oncology Network, P.A., in colloboration with the
Florida Hospital
Cancer Institute are proud in helping to bring to central Florida a variety
of new cancer treatment programs and techniques.
|
|
Florida Hospital treats the largest number of women in the state with a new diagnosis
of breast cancer. Our Breast Care Program, a multidisciplinary approach
to the care of the woman with breast cancer, has received strong praise from our patients
and the surrounding medical community.
Until recently, the treatment results of patients with recurrent or refractory
(unresponsive to conventional chemotherapy) non-Hodgkin's lymphoma has been disappointing.
ZevalinTM, is the first radioimmunotherapy
agent approved by the FDA. Radioimmunotherapy is a new area of cancer treatment that combines the targeting
power of monoclonal antibodies with the cell-killing ability of localized radiation.
Florida Hospital has a full array of the latest treatment techniques and research protocols
for the treatment of primary brain tumors and cancers metastatic to the brain. In addition to
our strong Gamma Knife stereotactic radiosurgery program,
we now offer treatment with the GliasiteTM Brachytherapy System.
This technique is yet another approach for delivering highly localized radiotherapy to a tumor
resection cavity.
|
|
